Because cancer cells can be genetically different even a centimeter apart within the same tumor, a single targeting agent will inevitably miss some malignant tissue. The solution is a 'cocktail' of multiple tumor-targeted dyes, each targeting a different marker, to ensure visualization of virtually all cancer variants in a patient.

Dr. Deb Schrag predicts that future medical innovations, especially in AI, will depend on collaborations beyond traditional medical specialties. Oncologists must now partner with engineers, computational scientists, and physicists to translate complex technologies into clinical practice.

Drawing an analogy from neuroscience, Noetik argues for a top-down modeling approach. Instead of building a perfect simulation of a single cell and scaling up, they model the functional interactions at the tissue level first. This abstraction is more likely to predict patient-level outcomes, which is the ultimate goal.

The progress of AI in predicting cancer treatment is stalled not by algorithms, but by the data used to train them. Relying solely on static genetic data is insufficient. The critical missing piece is functional, contextual data showing how patient cells actually respond to drugs.

The next frontier in preclinical research involves feeding multi-omics and spatial data from complex 3D cell models into AI algorithms. This synergy will enable a crucial shift from merely observing biological phenomena to accurately predicting therapeutic outcomes and patient responses.

By training on data across many cancer types ("pan-cancer"), AI models learn universal biological principles. This approach allows them to generalize learnings from large, common cancer datasets to significantly improve prediction accuracy for rare cancers, which often suffer from a lack of specific data for training effective models.

A tumor can be viewed as an evolving system within the body's environment. It progresses from stage to stage by "ratcheting up" its functional information—its ability to survive and grow. This evolutionary framework could inspire novel cancer treatments.

Genomic data (DNA) provides a static blueprint of potential, not a view of the actual biological activity. True understanding requires measuring the dynamic interactions of molecules and cells within tissues "downstream." Current methods capture only fragmentary slices, missing the full picture.

Traditional science failed to create equations for complex biological systems because biology is too "bespoke." AI succeeds by discerning patterns from vast datasets, effectively serving as the "language" for modeling biology, much like mathematics is the language of physics.